Global Tech News Palestine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech News Palestine.

Press releases published on March 16, 2026

Mar. 16, 2026

NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer

Indeterminate GlobeNewswire

Mar. 16, 2026

Aurora Mobile Establishes Japanese Subsidiary to Redefine AI-Powered Customer Interaction and Security

Indeterminate GlobeNewswire

Mar. 16, 2026

Allot to Participate in the 38th Annual Roth Conference on March 23-24, 2026

Indeterminate GlobeNewswire

Mar. 16, 2026

Outsourcing provider Yempo Solutions to help UK businesses lower cost of operations, to run roadshow in May 2026

Indeterminate GlobeNewswire

Mar. 16, 2026

MONUMENTAL ENERGY ANNOUNCES COMMERCIAL PRODUCTION AT WAIHAPA H1

Indeterminate GlobeNewswire

Mar. 16, 2026

Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio

Indeterminate GlobeNewswire

Mar. 16, 2026

Super Vision Technology’s i-NYS Implantable Device Approved in China, Breaking the Treatment Barrier for Congenital Nystagmus

Indeterminate GlobeNewswire

Mar. 16, 2026

Mawson Infrastructure Group Inc. Provides Update on Strategic Initiatives

Indeterminate GlobeNewswire

Mar. 16, 2026

General (Ret.) Anthony Cotton, Former STRATCOM Commander, Joins Pallas Speakers Bureau

Indeterminate GlobeNewswire

Mar. 16, 2026

Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01

Indeterminate GlobeNewswire

Mar. 16, 2026

Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting

Indeterminate GlobeNewswire

Mar. 16, 2026

POMA AI Achieves Best-in-Class RAG Chunking and Document Ingestion With 77% Token Reduction vs. Conventional Models

Indeterminate GlobeNewswire

Mar. 16, 2026

LigoLab Highlights AI and Automation Insights at LigoVerse 2026

Indeterminate GlobeNewswire

Mar. 16, 2026

BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start

Indeterminate GlobeNewswire

Mar. 16, 2026

InnoCare Announces First Healthy Volunteer Dosed in Clinical Trial of Novel VAV1 Degrader ICP-538 in China

Indeterminate GlobeNewswire